Journey Medical Corp (DERM)
5.54
+0.34
(+6.54%)
USD |
NASDAQ |
Nov 22, 13:33
Journey Medical Gross Profit Margin (Quarterly): 63.87% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.87% |
| June 30, 2024 | 55.97% |
| March 31, 2024 | 47.69% |
| December 31, 2023 | 60.58% |
| September 30, 2023 | 81.39% |
| June 30, 2023 | 54.77% |
| March 31, 2023 | 47.20% |
| December 31, 2022 | 51.66% |
| September 30, 2022 | 55.19% |
| Date | Value |
|---|---|
| June 30, 2022 | 58.27% |
| March 31, 2022 | 64.79% |
| December 31, 2021 | 45.62% |
| September 30, 2021 | 43.05% |
| June 30, 2021 | 51.05% |
| March 31, 2021 | 63.54% |
| December 31, 2020 | 68.80% |
| September 30, 2020 | 64.23% |
| June 30, 2020 | 66.82% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
43.05%
Minimum
Sep 2021
81.39%
Maximum
Sep 2023
58.03%
Average
57.12%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Fortress Biotech Inc | 63.87% |
| Heron Therapeutics Inc | 71.17% |
| Eton Pharmaceuticals Inc | 61.04% |
| Elutia Inc | 46.28% |
| NovaBay Pharmaceuticals Inc | 65.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -125.8% |
| Return on Assets | -27.08% |
| Return on Invested Capital | -64.68% |
| Profit Margin (Quarterly) | -16.34% |
| Operating Margin (Quarterly) | -19.78% |
| Return on Net Operating Assets | -44.68% |